Subsequently, it was found that inhibition of PARP1 led to an improvement in inflammatory disorders via suppression of NF-κB [24] and that PARPi were a means of targeting cancer cell apoptosis through their effect on the NF-κB signaling pathway in HCC [25]. Here, PARP1 is linked to hepatocellular carcinoma.